Bradley Merrill, PhD


Department of Biochemistry and Molecular Genetics

College of Medicine

Research Program

Cancer Biology (CB)

Phone: 312-996-0346

Email: [email protected]

Dr. Merrill’s group has had a longstanding interest in the Wnt/beta-catenin signaling pathway and how it affects cellular properties important for stem cells and cancers. Recently, his group developed new CRISPR/Cas9 based technologies to provide cells sets of instructions, which can be executed in a preprogrammed, sequential order of events. These technologies are being used for several applications, including the recording historical information about a cell within its genome.


PhD, University of California

Disease Focus

Breast; Hematologic; Colorectal; Liver

Research Keywords

Wnt/beta-catenin; Crispr; Cas9; Stem Cell; Synthetic Biology; Transcription Factor; Genome Editing

Published Research

PubMed Search

Other Link(s)

Department Webpage

Translate »